Live Online Training: Supply Chain Oversight Im Auftrag der ECA Academy
28/29 October 2020
Seminar-Nr. 18287
Referent:innen
Dr Ulrich Kissel
European QP Association (EQPA), KisselPharmaConsulting
Cheryl Chia
Lotus Phoenix Consulting
All times mentioned are CET.
Zielsetzung
This 2-day Live Online Training brings together well-experienced experts to discuss the latest expectations and best practices for effective and efficient Supply Chain Oversight processes and how to get there.
Hintergrund
There is a steady increase in dependence on global supply chains. Pharmaceutical companies not only source starting materials from all over the world, but also outsource manufacturing activities. The finished products are then distributed globally. These complex supply chains with different transport routes and manufacturing locations lead to major challenges in terms of maintaining the quality of materials, intermediates and medicinal products.
This has increased the risk of potential compliance and delivery problems, having a negative impact on a company‘s business and on the patient. Managing these supply chains and complying with GMP and GDP regulations require a comprehensive supply chain oversight with appropriate risk management measures.
The manufacturer, the Qualified Person (QP) but also the Responsible Person (RP) are primarily responsible for compliance with EU/EEA requirements:
EU-GMP Annex 16, General principles: “The ultimate responsibility for the performance of a medicinal product over its lifetime, its safety, quality and efficacy, lies with the marketing authorisation holder (MAH).”
EU-GMP Annex 16, 1.7.2: “The entire supply chain of the active substance and medicinal product up to the stage of certification is documented and available for the QP. This should include the manufacturing sites of the starting materials and packaging materials for the medicinal product and any other materials deemed critical through a risk assessment of the manufacturing process. The document should preferably be in the format of a comprehensive diagram…”
In the meantime, the competent authorities and inspectorates are also focusing on supply chain oversight processes; manufacturers and especially the marketing authorisation holder must know and control every level of the supply chain.
Zielgruppe
QPs, RPs, Managers and Executives from pharmaceutical Quality and Supply Chain Units but also Senior Management, Business Executives and those involved in improving and controlling the pharmaceutical supply chain.
Technical Requirements
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings. At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
Responsibilities of MAH, QP and RP in the overall supply chain
What do inspectors expect?
Supply Chain Oversight (1): from Development to Transfer
How to keep oversight over the pool of suppliers and brokers in the development phase (supplier change controls, ongoing supplier management incl. trending)
Initiation, creation and management of compliant and useful supply chain diagrams (with examples)
How to use risk analysis and management
Transfer of the information: the “QP-QP handshake”
Supply Chain Oversight (2): from Transfer to Life Cycle Management
Transfer of the information: the “QP-QP handshake”
Management and change control of compliant and useful supply chain diagrams (with examples)
How to keep oversight over the pool of suppliers and brokers in the marketing phase (supplier change controls, ongoing supplier management incl. trending)
Master Data in the Supply Chain
The broader framework on Master Data
How will this impact the pharmaceutical Supply Chain?
What does this mean for supply chain organisations?
What does this mean for the quality organisations supporting the supply chain?
Become a master of your data!
Block Chain Technology in the Supply Chain
What is block chain and how could it help supply chains?
Block chain for supply chains – a must or a maybe?
Examples of block chain being used in supply chains
Understand the components of the supply chain based on a hypothetical example (Material flow, Information flow, Capital flow)
Barriers, challenges and solutions.
Serialisation Issues
Challenges and problems occurring in the supply chain and how to deal with them
Import and Export
Annex 21: possible consequences
The Release to third Countries
Who is releasing products in markets outside EU (after EU QP certification) – and how
Best practices - what needs to be considered
Contract Handling
Different contracts in the Supply Chain (Forecasting, Supply, Quality/ Technical Agreement …)
Who needs to sign
Contract handling: how to keep them up to date, how to avoid contradictions
Change Control and Certification for global Markets
How to deal with change control challenges when regular approvals can take several months or years to cover all the relevant countries worldwide
How to support decision making
The link to ICH Q12
From Incident to Quality Review
Different types of queries/complaints
Who deals with which types of queries/complaints?
Examples of distribution complaints
Investigation and CAPAs
Trending
Quality Reviews
Dieses Seminar/Webinar kann nicht gebucht werden. Alternative Termine für dieses Seminar/Webinar und ähnliche Veranstaltungen finden Sie in der Liste aller Seminare.
Für viele Seminare und Webinare gibt es auch Aufzeichnungen, die Sie jederzeit bestellen und anschauen können. Diese Aufzeichnungen finden Sie in der Liste aller Aufzeichnungen.
Oder senden Sie uns Ihre Anfrage einfach über das folgende Kontaktformular.
Teilnehmerstimmen - das sagen andere über unsere Seminare:
„Flüssiger Vortrag, neue Aspekte wurden kommuniziert.“ Rainer Tryankowski, DRK-Blutspendedienst Rheinland-Pfalz und Saarland Webinar GDP Update 2025 März 2025
„Sehr guter Überblick über die aktuellen GDP Themen. Sehr kurzweilig.“ Juliana Dodillet, Pharma Resources GmbH Webinar GDP Update 2025 März 2025
„Sehr ausführliche Erklärung“ Jacqueline Buckel, UNITAX-Pharmalogistik GmbH Webinar GDP Update 2025 März 2025
„Sehr gut: praxisorientiert; Präsentation logisch nachvollziehbar“ Gabriele Unger, Astro-Pharma GmbH Webinar GDP Update 2025 März 2025
„Sehr informativ und umfangreich, aber immer auf den Punkt gebracht“ Jasmine Merz, Peppler GmbH Webinar GDP Update 2025 März 2025